Bio-Thera Solutions
Registry sponsor category
Industry
- Other names
- Bio-Thera Solutions
- Company name
- Bio-Thera Solutions
- Organisation type
- Industry
- Registry sponsor category
- Industry
- Publicly traded (proxy)
- No
- Listing at source
- Listed
Related records
Trials (57)
- A Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy of the Combination of BAT8008 With BAT1308 in Patients With Advanced Solid Tumors
- A Clinical Study of BAT4406F Injection in Patients With Minimal Change Disease/Focal Segmental Glomerulosclerosis
- A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer
- A Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
- A Clinical Trial of BAT8001 on Safety, Tolerability and Pharmacokinetics for Patients
- A Comparative Pharmacokinetic Study to Evaluate Different Manufacturing Batches of BAT1706 Injection
- A Comparative Study of BAT1706 and EU Avastin® in Patients With Advanced Non Squamous Non Small Cell Lung Cancer
- A Multicenter Open Clinical Study of Safety, Tolerability, Pharmacokinetic Profile, and Initial Clinical Efficacy of BAT 8010 for Injection Combined With BAT 1006 in the Treatment of Locally Advanced or Metastatic Tumors
- A Phase 1/2 Study to Assess Safety and Efficacy of BAT2020 in Hospitalized COVID-19 Patients
- A Phase I Clinical Trial of BAT1306 and BAT8001 Injection in Patients With Solid Tumor
- A Phase I Clinical Trial of BAT4306F on Safety, Tolerability and Pharmacokinetics for Patients
- A Phase I Clinical Trial of BAT4406F Injection in Patients With Neuromyelitis Optica Spectrum Disorders
- A Phase I Clinical Trial of BAT5906 Injection in Patients With Wet Age-related Macular Degeneration
- A Phase III Study Evaluate the Efficacy and Safety of BAT1406 and Humira
- A Randomized, Double-blind, Single-dose, Two-arm Parallel Study to Compare the Pharmacokinetics and Safety of BAT1806 Prefilled Subcutaneous Injection With RoActemra® in Healthy Chinese Male Subjects
- A Study Evaluating BAT3306 Compared With Keytruda® in NSCLC Cancer Participants
- A Study on Pharmacokinetics and Safety of BAT2506 Injection Versus Simponi®
- A Study to Evaluate PK, Efficacy, and Safety of BAT3306 Plus Chemo and Compare With Keytruda®(EU/US) in Participants With IV nqNSCLC
- Assess Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of BAT8009
- Assessment of Safety , Clinical Efficacy with QLETLI in Non-infectious Uveitis (UV)